Search

everythinglearnresearchcommunity

for

Search:↓

A new method accurately measures nine specific hormones in human blood.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

New method measures finasteride in blood quickly and accurately.

Telemedicine is effective for sexual medicine consultations.

Robotic systems in hair transplant surgery are safe, reliable, and as efficient as manual methods, with high patient satisfaction.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Rats had lasting erectile problems after stopping a certain medication.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Proper treatments based on tests can improve life quality and protect kidneys in Parkinson's patients with bladder issues.

Methods accurately measure tamsulosin hydrochloride and finasteride in combined dosages.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Finasteride may help treat BPH by affecting certain biological markers.

COVID-19 worsens urinary symptoms in men with benign prostatic hyperplasia, requiring careful treatment management.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

Finasteride may increase iris billowing risk during surgery, similar to tamsulosin.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.